1. Dudzinska E, Strachecka A, Gil-Kulik P, et al. (2020): Influence of the treatment used in inflammatory bowel disease on the protease activities. Int J Gen Med 13: 1633-1642.
2.
Pan Y, Ning Y, Hu J, et al. (2021): The preventive effect of Lactobacillus plantarum ZS62 on DSS-induced IBD by regulating oxidative stress and the immune response. Oxid Med Cell Longev 2021: 9416794.
3.
Yuan S, Wang Q, Li J, et al. (2022): Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment. Chin Med 17: 74.
4.
Li X, Zhang M, Zhou G, et al. (2023): Role of Rho GTPases in inflammatory bowel disease. Cell Death Discov 9: 24.
5.
Bao S, Liu W, Liu L, et al. (2022): Analysis of factors related to spiritual psychology and quality of life in patients with inflammatory bowel disease based on artificial intelligence IBD nursing technology. J Healthc Eng 2022: 7702432.
6.
Ishikawa T, Hamel M, Zhu BL, et al. (2008): Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein. Forensic Sci Int 179: 135-143.
7.
Zhou X, Shao Y, Li S, et al. (2022): An intravenous anesthetic drug-propofol, influences the biological characteristics of malignant tumors and reshapes the tumor microenvironment: A narrative literature review. Front Pharmacol 13: 1057571.
8.
Chen SW, Wang PY, Liu YC, et al. (2016): Effect of long noncoding RNA H19 overexpression on intestinal barrier function and its potential role in the pathogenesis of ulcerative colitis. Inflamm Bowel Dis 22: 2582-2592.
9.
Padua D, Mahurkar-Joshi S, Law IK, et al. (2016): A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation. Am J Physiol Gastrointest Liver Physiol 311: G446-457.
10.
Ren Z, Liu X, Si Y, et al. (2020): Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis. Artif Cells Nanomed Biotechnol 48: 572-583.
11.
Tian JB, Cao L, Dong GL (2019): Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis. Eur Rev Med Pharmacol Sci 23: 5714-5729.
12.
Li Q, Wang S, Wu Z, et al. (2020): DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p. Biomed Pharmacother 127: 110164.
13.
Si X, Zhang G, Li M, et al. (2023): LncRNA DDX11-AS1 promotes chemoresistance through LIN28A-mediated ATG12 mRNA stabilization in breast cancer. Pharmacology 108: 61-73.
14.
Chen D, Liu J, Zhao HY, et al. (2016): Plasma long noncoding RNA expression profile identified by microarray in patients with Crohn’s disease. World J Gastroenterol 22: 4716-4731.
15.
Lee LK, Medzikovic L, Eghbali M, et al. (2020): The role of microRNAs in acute respiratory distress syndrome and sepsis, from targets to therapies: A narrative review. Anesth Analg 131: 1471-1484.
16.
Naganuma M, Hirai F, Kobayashi K, et al. (2019): Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam. PLoS One 14: e0220413.
17.
Hirsch A, Scapa E, Fliss-Isakov N, et al. (2023): Early initiation of adalimumab significantly diminishes postoperative Crohn’s disease endoscopic recurrence and is superior to 6-mercaptopurine therapy: An open-label, randomized controlled study. J Clin Med 12: 7600.
18.
Wei YY, Fan YM, Ga Y, et al. (2021): Shaoyao decoction attenuates DSS-induced ulcerative colitis, macrophage and NLRP3 inflammasome activation through the MKP1/NF-kappaB pathway. Phytomedicine 92: 153743.
19.
Dushianthan A, Cusack R, Goss V, et al. (2012): Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome – where do we go from here? Crit Care 16: 238.
20.
Zhang YZ, Li YY (2014): Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20: 91-99.
21.
He BJ, Liu ZK, Shen P, et al. (2022): Epidemiological study on the incidence of inflammatory bowel disease in Yinzhou District, Ningbo City from 2011 to 2020. Beijing Da Xue Xue Bao Yi Xue Ban 54: 511-519.
22.
Goodman WA, Erkkila IP, Pizarro TT (2020): Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 17: 740-754.
23.
Choi HH, Cho YS (2017): Disability index as a new outcome measure in patients with inflammatory bowel disease. Gut Liver 11: 319-320.
24.
Feng Y, Wu M, Hu S, et al. (2020): LncRNA DDX11-AS1: a novel oncogene in human cancer. Hum Cell 33: 946-953.
25.
Luan F, Chen W, Chen M, et al. (2019): An autophagy-related long non-coding RNA signature for glioma. FEBS Open Bio 9: 653-667.
26.
Ma F, Sun M, Song Y, et al. (2022): Lactiplantibacillus plantarum-12 alleviates inflammation and colon cancer symptoms in AOM/DSS-treated mice through modulating the intestinal microbiome and metabolome. Nutrients 14: 1916.
27.
Yao X, Huang J, Zhong H, et al. (2014): Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther 141: 125-139.
28.
Iriarte A, Zaera C, Bachiller-Corral J, et al. (2017): Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy. Gastroenterol Hepatol 40: 117-121.
29.
Aghamohamadi E, Asri N, Odak A, et al. (2022): Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases. Mol Biol Rep 49: 6085-6091.
30.
Zhu H, Tong S, Cui Y, et al. (2021): Tanshinol alleviates ulcerative colitis by promoting the expression of VLDLR. Drug Dev Res 82: 1258-1268.
31.
Guo S, Al-Sadi R, Said HM, et al. (2013): Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol 182: 375-387.
32.
Undseth R, Berstad A, Valeur J (2016): Systemic symptoms in irritable bowel syndrome: An investigative study on the role of enterocyte disintegrity, endotoxemia and inflammation. Mol Med Rep 14: 5072-5076.
33.
Liu J, Yao Y, Huang J, et al. (2022): Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells. BMC Genomics 23: 425.
34.
Ye J, Tan L, Fu Y, et al. (2019): LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p. J Cell Biochem 120: 19775-19783.
35.
Yang F, Li XF, Cheng LN, et al. (2019): Long non-coding RNA CRNDE promotes cell apoptosis by suppressing miR-495 in inflammatory bowel disease. Exp Cell Res 382: 111484.
36.
Song J, Sun J, Wang Y, et al. (2023): CeRNA network identified hsa-miR-17-5p, hsa-miR-106a-5p and hsa-miR-2355-5p as potential diagnostic biomarkers for tuberculosis. Medicine (Baltimore) 102: e33117.
37.
Liang Y, Jie H, Liu Q, et al. (2022): Knockout of circRNA single stranded interacting protein 1 (circRBMS1) played a protective role in myocardial ischemia-reperfusion injury though inhibition of miR-2355-3p/Mammalian Sterile20-like kinase 1 (MST1) axis. Bioengineered 13: 12726-12737.
